Summary
The cellular interactions involved in the platelet response after immunoglobulin infusion in acute and chronic idiopathic thrombocytopenic purpura (ITP) are unknown. There have been a number of theories including the competitive inhibition of platelet-binding to macrophages by the preferential sequestration of immunoglobulin coated red cells. We report a study to examine this hypothesis. Adult acute and chronic patients were given infusions of immunoglobulin at a rate of 0.4 g/kg body weight, daily for 5 days. Serum haptoglobin, lactate dehydrogenase and the absolute reticulocyte counts were monitored and no significant change in any value was seen during the period of study. A red cell survival was performed on four of the patients and no increase in the rate of red cell clearance occurred during the infusion period. We conclude from this that in these patients no significant degree of haemolysis was provoked by the infusion although this does not preclude this as a mechanism of action in some individuals.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
A report by the ICSH panel on diagnostic applications of radioisotopes in haematology (1971) Recommended methods for radio-isotope red cell survival studies. Br J Haematol 21: 241–250
Atrah HI, Crawford RJ (1984) Blood group and response to immunoglobulin in immune thrombocytopenia. Lancet 2: 577
Boorman KE, Dodd BE, Lincoln PL (1977) In Blood group serology. 5th edition (1977). Theory techniques. Practical application. Chapter 22. Identification and mixtures of antibodies. Churchill Livingston, Edinburgh, London, New York, pp 279–306
Budde V, Schäfer G, Niese D, Schmidt RE (1983) Intravenous immunoglobulin in immune thrombocytopenia. Lancet 2: 578
Bussel JB, Hilgartner M (1984) The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease. Br J Haematol 56: 1–7
Bussel JB, Jaisson F, Janvier M, Traulle C, Schenmetzer C (1983) Utilisation des gammaglobulines intraveineuse a fortes doses dans le traitment des anemies hemolytiques autoimmunes. Presse Med 41: 2628
Costea N, Schwartz R, Constantoulakis M, Dameshek W (1962) The use of radioactive antiglobulin for the detection of erythrocyte sensitization. Blood 20: 214–232
Dammacco F, Iodice G, Campobasso N (1986) Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin; effects on circulating T cell subsets and PWM induced antibody synthesis in vitro. Br J Haematol 62: 125–155
Evans RS, Duane RT (1949) Acquired haemolytic anaemia. Blood 4: 1196–1212
Evans RS, Takahashi K, Duane RT (1951) Primary thrombocytopenic purpura and acquired haemolytic anaemia. Arch Intern Med 87: 48–65
Fehr J, Hofmann V, Kappeler V (1982) Transient reversal of thrombocytopenia by high dose intravenous gammaglobulin. New Engl J Med 306: 1254–1258
Imbach P, Barandun S, d'Apuzzo V, Baumgarten C, Hirt A, Morrel A, Rossi E, Schoni M, Vest M, Wagner HP (1981) High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in children. Lancet 2: 1228–1231
Imbach P, Jungi TW (1983) Possible mechanisms of intravenous immunoglobulin treatment in childhood idiopathic thrombocytopenic purpura (ITP). Blut 46: 117–124
Imbach P, Jungi T, Barandun S (1983) Intravenous immunoglobulin in immune thrombocytopenia. Lancet 2: 577
Kavai M, Zsindely A, Sonkoly I, Major M, Demjan I, Szegedi G (1983) Signals of monocyte activation in patients with SLE. Clin Exp Immunol 51: 255–260
Newland AC, Treleaven JG, Minchinton RM, Waters AH (1983) High dose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet 1: 84–87
Newland AC (1985) Intravenous immunoglobulin therapy in adult idiopathic thrombocytopenic purpura. In Intravenous Immunoglobulins. Waters AH and Webster ADB eds. 1985. Royal Society of Medicine International Congress and Symposium Series No. 84. Published by the Royal Society of Medicine pp 93–100
Newland AC, Macey MG, McAvinchey RP, Jones L (1984) The effect of intravenous IgG on reticulo-endothelial function and autoimmune thrombocytopenia (Abstract). Br J Haematol 58: 178
Macintyre EA, Linch DC, Macey MG, Newland AC (1985) Successful response to intravenous immunoglobulin in auto immune haemolytic anaemia. Br J Haematol 60: 387–388
Mueller-Eckhardt C, Salama A, Kiefel V, Küenzlen E, Förster C (1984) A new concept for the effector mechanism of intravenous immunoglobulin in hemocytopenias. Blut 48: 352–356
Salama A, Mueller-Eckhardt C, Kiefel V (1983) Effect of intravenous immunoglobulin in immune thrombocytopenia. Competitive inhibition of the reticuloendothelial system function, by sequestration of autologous red blood cells. Lancet 2: 193–195
Schrieber AD (1985) Quantitation of RBC-Band Immunoglobulin and Complement Components. In: Chaplin H (ed) Immune Haemolytic Anaemias. Churchill, Livingstone, pp 155–175
Shulman NR (1964) A mechanism of cell destruction in individuals sensitized to foreign antigens and its implications in auto-immunity. Ann Intern Med 60: 56–521
Tsubakio T, Kurata Y, Katagiris S, Kanakura Y (1983) Alteration of T cell subsets in vitro during high dose gamma globulin therapy in patients with idiopathic thrombocytopenic purpura. Clin Exp Immunol 53: 697–702
Wilkinson JH (1965) In Principles and practice of diagnostic enzymology (1st Edit) Edward Arnold, London, pp 46–54
Zücker-Franklin D, Karpatkin S (1977) Red cell and platelet fragmentation in idiopathic thrombocytopenic purpura. New Engl J Med 297: 517–523
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Macey, M.G., Macintyre, E.A. & Newland, A.C. Red cell sequestration during high dose intravenous immunoglobulin in idiopathic thrombocytopenic purpura. Blut 53, 77–87 (1986). https://doi.org/10.1007/BF00321090
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00321090